06/11/2019

Giovannelli e Associati advised Neopharmed Gentili on the acquisition of Mdm

Giovannelli e Associati advised Neopharmed Gentili, a pharmaceutical company specialized in the market of high therapeutic value solutions controlled by Ardian together with Del Bono Family, […]
25/10/2019

Giovannelli e Associati advised MooRER S.p.A and the controlling shareholder Moreno Faccincani on the sale of a minority stake to Borletti Group

Giovannelli e Associati advised MooRER SpA and the controlling shareholder Moreno Faccincani, on the sale of a minority stake to Borletti Group. MooRER SpA is a […]
25/10/2019

Giovannelli e Associati advised VP Immobiliare on the sale of a real estate property to Kryalos Opportunity Fund I

Giovannelli e Associati advised VP Immobiliare on the sale of an office building located in Milano, in the Tortona/Savona district, to Kryalos Opportunity Fund I. The […]
08/10/2019

Giovannelli e Associati advised Italmatch Chemicals Group on the investment in FRX Polymers, Inc.

Giovannelli e Associati advised Italmatch Chemicals Group, a portfolio company of Bain Capital, on the investment in FRX Polymers, Inc., the Boston-based USA manufacturer focused on […]